Table 3.

Baseline virological and histological features of HCV sustained virological responders (SVR) against non-responders (NR).

Virological and histological features	SVR (n = 86)		NR (n = 74)		χ2	P
	Size (n)	Frequency (%)	Size (n)	Frequency (%)
HCV-RNA Level, before therapy
Low viral load	43	50.0	27	36.5	3.1	NS
Moderate viral load	39	45.3	37	50.0	0.2	NS
High viral load	4	4.7	10	13.5	3.6	NS
HCV-RNA Level, after therapy
Low viral load	0	0	30	40.5	48.3	S*
Moderate viral load	0	0	38	51.4	66.6	S*
High viral load	0	0	6	8.1	6.3	S
Metavir Scoring System, before therapy
Activity Score
A0/1	72	83.7	52	70.3	4.3	S
A2/3	14	16.3	22	29.7	4.3	S
Fibrosis Score
F0/1	54	62.8	18	24.3	28.6	S*
F2	20	23.3	30	40.5	6.04	S
F3/4	12	13.9	26	35.2	11.1	S
Metavir Scoring System, after therapy
Activity Score
A0/1	76	88.4	44	59.5	20.2	S*
A2/3	10	11.6	30	40.5	20.2	S*
Fibrosis Score
F0/1	56	65.1	30	40.5	11.1	S
F2	24	27.9	12	16.2	3.3	NS
F3/4	6	7	32	43.3	33.0	S*

n: size of samples.

NS: represents no significant difference.

S: represents significant difference with Chi-square value (χ² > 3.84).

S*: high significant difference with Chi-square value (χ² > 3.84).